Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. (JUNS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · JUNS · as of Jun 9, 2026
Key Statistics
Explore Jupiter Neurosciences, Inc. Data
juns stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
juns competitorsJUNS
ABVC
ALGS
FGEN
GNTA
GRCEStock Performance
Full HistoryAbout Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main object…
what is jupiter neurosciences, inc. · juns stock overview · jupiter neurosciences, inc. company profile · who is jupiter neurosciences, inc. ceo · juns NASDAQ · jupiter neurosciences, inc. headquarters · jupiter neurosciences, inc. business segments
About Stock Overview & Key Data
Jupiter Neurosciences, Inc. (JUNS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 18, 2022. As of the latest trading session, JUNS stock price is $0.23, with a market capitalization of $8.2M. The stock has returned -73.84% over the past 12 months and -76.94% year-to-date.
In fiscal year 2025, Jupiter Neurosciences, Inc. reported revenue of $21796.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Jupiter Neurosciences, Inc. (JUNS) stock price is $0.23. The stock is traded on NASDAQ under the ticker symbol JUNS. The 52-week range is $0.17 – $3.33.